Health · 16 July 2026

Your future Alzheimer's risk could be prevented

About 1,600 people at high risk of Alzheimer's will take a new drug called trontinemab in trials across the world. Scientists hope the monthly infusion, made by Swiss firm Roche, will prevent symptoms by removing brain plaques more effectively. Trontinemab could lead to Alzheimer's being treated preventively, similar to heart disease medications.

By BriefTea Editorial · 16 July 2026 at 1:22

Reported by Daily Express · How we write briefs

Get the app

More briefs

HealthGreat Ormond Street's Same-Day Test Finds Hidden Infections in Sick Children HealthImmune cell found to kill small cell lung cancer in lab tests HealthDiabetics sleeping 8+ hours face nearly double kidney disease risk HealthNo perfect age to start HRT, but benefits peak before 60, experts say HealthOver 12,000 fake weight-loss pens worth £2m seized in Birmingham raid HealthTrans patients in England to go on wards matching birth sex More health stories → Browse all stories →